Inogen stock has experienced downward pressure and periodic valuation contractions due to mixed financial reporting, pressures within the U.S. direct-to-consumer sales channels, and management's adjustments to full-year revenue guidance. While international markets have posted consecutive quarters of double-digit growth, domestic retail headwinds and cautious investor sentiment surrounding near-term profitability timelines have weighed heavily on equity performance.